Avanos MedicalAVNS
Market Cap: 1.06B
About: Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Employees: 3,771
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
28% more call options, than puts
Call options by funds: $465K | Put options by funds: $363K
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2023] → 1 (+0) [Q1 2024]
0.81% less ownership
Funds ownership: 94.63% [Q4 2023] → 93.82% (-0.81%) [Q1 2024]
3% less funds holding
Funds holding: 259 [Q4 2023] → 251 (-8) [Q1 2024]
12% less capital invested
Capital invested by funds: $986M [Q4 2023] → $863M (-$123M) [Q1 2024]
20% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 41
44% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 97
Research analyst outlook
We haven’t received any recent analyst ratings for AVNS.
Financial journalist opinion
Based on 3 articles about AVNS published over the past 30 days